News Category
Quantum BioPharma files a supplement to clarify share consolidation rounding and voting power caps, aiming to ensure a smooth shareholder vote on Nove...
Leading scientists will gather in Boston for the 2026 Activated Egg Symposium to address fundamental questions about how human eggs activate, with imp...
A German federal court's ruling that CeramTec's pink trademark for ceramic hip components was filed in bad faith strengthens CoorsTek Bioceramics' com...
Annovis Bio has priced a $21 million public offering to advance clinical development of its oral therapy buntanetap for Alzheimer's and Parkinson's di...
Kairos Pharma received the 2026 Biotech Breakthrough Award for its investigational therapy ENV-105, which aims to overcome treatment resistance in met...
Scinai Immunotherapeutics posted 167% revenue growth to $2.8 million for the nine months ended Sept. 30, 2026, driven by CDMO expansion, and reported ...
Annovis Bio's proposed public offering aims to raise capital to advance its lead drug candidate buntanetap through Phase 3 trials for Alzheimer's and ...
Viromed Medical AG has received approval for its ViroCAP® med cold plasma device in Turkey ahead of schedule, with binding orders for 7,000 units thro...
Heidelberg Pharma will present new clinical data on its ATAC candidates, pamlectabart tismanitin (HDP-101) and HDP-102, at the 68th ASH Annual Meeting...
Tonix Pharmaceuticals' upcoming presentation at the Guggenheim Healthcare Innovation Conference highlights its commercial-stage CNS portfolio, includi...
Quantum BioPharma advances a broad strategy combining drug development, consumer wellness, and royalty partnerships to address the massive unmet need ...
The October 2026 Wellness Index Report highlights three experts who are shifting the focus from merely extending lifespan to engineering healthspan, w...
Sequencio Therapeutics will present new preclinical data at SITC 2026 showing its lead cancer vaccine candidates generated targeted immune responses a...
Quantum BioPharma's unbuzzd supplement, which showed significantly lower estimated blood alcohol concentration and improved alertness versus placebo i...
Kairos Pharma's ENV-105 doubled median progression-free survival in metastatic castration-resistant prostate cancer, potentially overcoming treatment ...
Adaptogenics Health Corp. is building its peptide strategy around supply verification and traceability as the FDA and HHS move toward a regulated pept...
Quantum BioPharma's unbuzzd supplement, designed to support alcohol metabolism, has drawn praise from Men's Fitness after a clinical trial showed prom...
ABVC BioPharma's $3.39 million private placement of original issue discount convertible notes provides working capital and funds a $625,000 settlement...
Tonix Pharmaceuticals appoints George Lederman as EVP of Strategy and Transformation, tasking him with leading AI initiatives and business development...
Okogen has dosed the first patient in its Phase 1/2 EMERALD trial of Treyegen for acute infectious conjunctivitis, a milestone that could validate its...
Catherine Cifuentes-Rojas has published a free five-question checklist to help biotherapeutics teams make disciplined early-stage investment decisions...
VERAXA Biotech is expanding its use of New Approach Methodologies (NAMs) to improve the clinical relevance of its antibody-based cancer therapies whil...
Quantum BioPharma's agreement with Thermo Fisher's clinical research business marks a key step toward launching Phase 2 trials for Lucid-MS, a novel m...
A dual-targeting antibody demonstrated profound effects in mice across multiple tumor types, offering a potential path to broaden the reach of cancer ...
Helix BioPharma cut its annual net loss by 36% while advancing its L-DOS47 oncology program and adding senior leadership, but with only $804,000 in ca...
Regentis Biomaterials' GelrinC hydrogel implant demonstrates significant pain reduction and cartilage regeneration, potentially addressing a large unm...
Annovis Bio CEO Maria Maccecchini will present at two November biotechnology conferences, highlighting the company's clinical programs and upcoming mi...
Oncotelic Therapeutics is leveraging its Partitioned Literature Aggregation algorithm to translate published liver cancer findings into a validated fo...
TransCode Therapeutics has launched a formal strategic review to explore options for maximizing value, including potential licensing, partnerships, or...
Enodia Therapeutics appoints Henrik Torp Nielsen as CFO to lead financial strategy as the company advances its Sec61 protein degradation platform towa...
Certified-PEP has published a 2026 comparison of 10 research peptide suppliers, revealing significant differences in documentation transparency and te...
A Phase 3 trial shows that combining two immunotherapy drugs significantly extends survival in patients with a deadly form of lung cancer, potentially...
VolitionRx's letter of intent with Missionpharma aims to develop and commercialize a low-cost NETosis diagnostic test, initially targeting neonatal se...
Creative Biolabs is promoting its CH50 functional test kit, hemolysis inhibition profiling service, and flow focusing droplet generation chip to help ...
NanoViricides' Phase IIA trial of NV-387 Oral Gummies for Ebola Bundibugyo is progressing, potentially offering the first oral treatment amid an outbr...
An early, mutated flu outbreak on the West Coast is prompting urgent vaccination calls and highlighting the need for decentralized testing tools from ...
Tonix Pharmaceuticals' TONMYA demonstrated significant improvements in fibromyalgia symptoms and physical function in Phase 3 trials, reinforcing its ...
GeoVax Labs has entered a $1 million revolving loan agreement with Bowery Consulting Group, which includes the appointment of three lender-nominated d...
Creative Biolabs is promoting its tumor organoid and immune cell co-culture services, including CAR-T models, to provide more physiologically relevant...
Creative Biolabs has launched an integrated OMV and exosome-boosted CAR-T development platform to help researchers address poor infiltration, immunosu...
GeoVax Labs has entered a $1 million revolving loan agreement with Bowery Consulting Group, a deal that reshapes its board and provides working capita...
TransCode Therapeutics announced that its Phase 1a trial of TTX-MC138 met its primary safety endpoint with no dose-limiting toxicities and showed dise...
Oncotelic Therapeutics published a peer-reviewed study showing its PDAOAI platform identified a four-gene prognostic signature in hepatocellular carci...
Tonix Pharmaceuticals will report third-quarter 2026 financial results on Nov. 9, an event that will give investors a first detailed look at the comme...
Coherence Neuro's $45 million Series A, backed by Peter Thiel and OpenAI, will fund first-in-human trials of its SOMA implant for glioblastoma, potent...
Adaptogenics Health Corp. is advancing a three-part business model combining peptide supply, proprietary therapeutics, and drug delivery technologies ...
Neovii Pharmaceuticals is advancing its FDA Fast Track-designated ATLG program into a pivotal Phase 2 trial for Type 1 Diabetes and appointing Dr. Sal...
Annovis Bio's three CTAD 2026 presentations on buntanetap's mechanism, Phase 3 trial design, and AI-driven blood-brain barrier prediction highlight th...
